SOFT: SOFT is based on systemic and solution-focused theories to change lifestyle and has shown positive effects on children with respect to the degree of obesity, physical fitness, self-esteem and family functioning.
TeleSOFT: The therapists communicate with the overweight child and his/her family by the SOFT method on distance by use of video.
Study summary
The present study is a public health project with the aim to treat overweight in children 9-11 years of age. After the first consultation the children are randomized to either continue the treatment at The Child Obesity Clinic, Child Department or to have the following 2-3 consultations on distance with Lync. Last visit for all children is on the Child Obesity Clinic after approximately 12 months. Follow up after at least 1 years will be performed.
Eligibility
Sex
ALL
Min age
9 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria:
\- Children with overweight and not obese according to the definitions developed by Cole et al (4). It implies that we include children with the following age specific BMI Inclusion criteria
* 9 years = AGE \< 9 years, 6 months AND 19,0\< BMI\<23,0
* 9 years, 6 months =\> AGE \< 10 Years AND 19,5 \<BMI\<23,5
* 10 years = AGE \< 10 years, 6 months AND 20,0\<BMI\<24,0
* 10 years, 6 months=\>AGE\< 11 years AND 20,5\<BMI\<24,5
* 11 years = AGE \< 11 years, 6 months AND 21,0\<BMI\<25,5
* 11 years, 6 months =\>AGE\<12 years AND 21,5\<BMI\<25,5
Exclusion Criteria:
* Children and his/her parents not able to communicate in Swedish.
* Children with monogenic obesity
* Present less than 80% at school in the latest school year.
* No foster care for the child or his/her brothers or sisters
Primary outcome measure(s)
Body mass index standard deviation score (BMI Z-score) during treatment of overweight — Change from Baseline in body weight at an average of 12 months Body weight measured by Tanita device
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.